Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CCS Cell Culture Service and Cytocentrics Agree Cooperation in the Field of Cell Line Development

Published: Monday, October 06, 2008
Last Updated: Monday, October 06, 2008
Bookmark and Share
The agreement is aimed at the development of electrophysiologically optimized ion channel cell lines which allow a reliable testing of substances and drugs.

Biotechnology companies CCS Cell Culture Service GmbH and Cytocentrics AG has announced the signing of a research and license agreement. The aim of the cooperation is to develop electrophysiologically optimized ion channel cell lines which allow a reliable testing of substances and drugs.

The pharmaceutical industry depends on suitable in-vitro test methods for preclinical drug screening and safety pharmacology testing. Over recent years the automated patch clamp technology has established itself in this field. However, in many cases the application of conventional recombinant cell lines results in low data quality.

The cooperation paves the way for the production of cell lines generating reliable and reproducible data in automated patch clamp systems. CCS brings its expertise in the production of recombinant cell lines into this partnership and Cytocentrics will focus on electrophysiological optimization.

"Combining the core competences of both companies will set new standards in the development of new drugs", explains Dr. Oliver Klotzsche, managing director and co-founder of the CCS Cell Culture Service GmbH. "Both companies have very high quality standards. The long experience of both companies allows professional work to be carried out in compliance with the high standards required by the pharmaceutical industry".

In detail the cooperation agreement comprises the production and optimization of cell lines expressing pharmacologically relevant ion channels. The first two cell lines hERG-HEK 293 and hNav1.5-CHO have recently become available for purchase.

“In our service sector for safety pharmacology testing, we are already successfully using cell lines which have been jointly developed", explains Dr. Christa Nutzhorn, President of Cytocentrics AG. “Customers from the pharmaceutical industry sector are completely satisfied with the high quality of measuring data."

Each batch of cells is subjected to quality controls prior to delivery. Quality standards refer to the seal rate, rate of whole-cell recordings, stability and existence of a homogenous flow. Customers can either acquire a license for a cell line or order so-called "Instant Cells", rendering unnecessary the time consuming cultivation of cells. These cells are ready-to-use in an assay within 15 minutes after defrosting.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!